For the three months ended September 30, 2025, Syndax reported a net loss attributable to common stockholders of $60.7 million, or $0.70 per share, compared to a net loss attributable to common ...
Thinking about starting a homemade butter business? Learn the key factors to consider — from legal requirements and food safety to production costs, branding, and selling strategies — to launch your ...
FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...
Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...
Moving labour out of low-productivity agriculture and into higher-productivity manufacturing is crucial for economic transformation in Africa. Expanding manufacturing production and exports, and ...
Are you a new Canadian investor and looking for a place to start? Here's an easy five-stock portfolio for a mix of growth, ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback